NewsBenzingaArrowhead Pharmaceuticals 的 REDEMPLO 获得英国上市许可,用于家族性乳糜微粒血症综合征;NICE 建议英格兰和威尔士为符合条件、经基因确诊的 FCS 成人提供 NHS 资助 Arrowhead Pharmaceuticals 的 REDEMPLO 获得英国上市许可,用于家族性乳糜微粒血症综合征;NICE 建议英格兰和威尔士为符合条件、经基因确诊的 FCS 成人提供 NHS 资助 Benzinga 2026.10.27 15:40 (GMT+0) Open on Benzinga Other news AI models can be tricked into identifying civilians as military targets by telling them it’s a game Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here. 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT